Pharma & Healthcare Logistics Market to Reach USD 216.8 Billion by 2036, Driven by Cold Chain Demand, Biopharmaceutical Supply Chains, and Direct-to-Patient Delivery at 7.1% CAGR

The global pharma & healthcare logistics market was valued at USD 102.0 Billion in 2025 and is projected to reach USD 216.8 Billion by 2036, expanding at a CAGR of 7.1% from 2026 to 2036. Market growth is being supported by rising demand for temperature-controlled transportation of biopharmaceuticals and specialty drugs, increasing clinical trial activity, and the growing complexity of global pharmaceutical supply chains.

Pharmaceutical companies, biotechnology firms, hospitals, pharmacies, clinical research organizations, and healthcare providers increasingly rely on specialized logistics services to transport, store, and distribute medicines, biologics, vaccines, medical devices, and clinical supplies.

The expansion of biologics, cell and gene therapies, vaccines, and other temperature-sensitive products is strengthening demand for advanced cold chain infrastructure. At the same time, digital technologies such as IoT-enabled monitoring, GPS tracking, predictive analytics, automation, and cloud-based supply chain management are improving shipment visibility and operational efficiency.

→Discover Market Opportunities - Request Your Sample Copy Now: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86988

Market Size and Highlights

The global pharma & healthcare logistics market reached USD 102.0 Billion in 2025 and is expected to reach USD 216.8 Billion by 2036, expanding at a 7.1% CAGR during 2026–2036.

North America dominated the market in 2025 with a revenue share of 39.5%, supported by its established pharmaceutical industry, advanced healthcare infrastructure, and extensive cold chain network. By service type, the transportation segment accounted for the largest market share of 43.1% in 2025.

Major companies operating in the market include DHL Group, Kuehne+Nagel International AG, UPS Healthcare, FedEx Corporation, DB Schenker, DSV A/S, GEODIS, and CEVA Logistics, among others.

Analysts’ Viewpoint on the Pharma & Healthcare Logistics Market

The global pharma & healthcare logistics market is witnessing steady expansion as pharmaceutical organizations, biotechnology companies, hospitals, and healthcare institutions increasingly depend on specialized logistics services to manage complex supply chains.

The growing volume of biologics, cell and gene therapies, vaccines, specialty medicines, and other temperature-sensitive products is increasing demand for advanced cold chain transportation, real-time monitoring, and compliant storage infrastructure. Requirements related to product safety, traceability, and Good Distribution Practice are also encouraging logistics providers to invest in advanced infrastructure and digital tracking systems.

Increasing pharmaceutical production and cross-border healthcare trade are creating additional requirements for transportation systems capable of maintaining product integrity throughout distribution. Pharmaceutical companies are increasingly forming strategic partnerships with logistics providers to strengthen distribution networks, reduce delivery risks, and improve access to healthcare products across international markets.

The emergence of personalized medicine and decentralized clinical trials is also creating new logistics requirements. Logistics providers are adopting IoT-enabled monitoring systems, predictive analytics, automation, and other digital technologies to improve supply chain visibility and operational efficiency.

Market Introduction

The pharma & healthcare logistics market comprises specialized transportation, warehousing, packaging, inventory management, and distribution services designed to support the safe movement of medicines, medical devices, vaccines, biologics, clinical supplies, and other healthcare products.

Healthcare logistics operations must comply with regulatory requirements and Good Distribution Practice standards while maintaining appropriate temperature conditions to protect product quality, efficacy, and patient safety. The market serves pharmaceutical manufacturers, biotechnology companies, hospitals, pharmacies, wholesalers, research institutions, and healthcare providers across domestic and international supply chains.

Increasing pharmaceutical production, growing demand for biologics and specialty medicines, and expansion of global clinical trial activity are strengthening demand for advanced logistics services. Cold chain logistics has become particularly important as the number of temperature-sensitive healthcare products increases.

Digital technologies including IoT-based tracking, RFID, GPS monitoring, warehouse automation, and cloud-based supply chain management solutions are improving shipment visibility and operational efficiency. As pharmaceutical supply chains become increasingly global and complex, dedicated healthcare logistics providers are investing in infrastructure, compliance capabilities, and integrated transportation networks.

Growing Demand for Temperature-Controlled Pharmaceutical Logistics Propels Market Growth

Increasing demand for temperature-sensitive pharmaceutical logistics is a major factor driving market expansion. The production of biologics, biosimilars, vaccines, cell and gene therapies, insulin, blood products, and other specialty pharmaceuticals is creating a growing requirement for reliable cold chain transportation and storage.

These products often require specific temperature ranges to maintain quality, stability, and efficacy. Requirements may include refrigerated conditions such as 2°C to 8°C, as well as frozen, ultra-low-temperature, and cryogenic environments. Temperature deviations during transportation can compromise product quality and result in significant losses.

Pharmaceutical companies and healthcare providers are therefore placing greater emphasis on validated packaging, refrigerated transportation, temperature sensors, and real-time monitoring systems. Good Distribution Practice requirements and quality-control standards are also encouraging logistics companies to strengthen cold chain capabilities.

The globalization of pharmaceutical manufacturing and cross-border distribution has further increased the complexity of transporting temperature-sensitive products. This is creating demand for specialized logistics providers with advanced infrastructure, digital monitoring capabilities, and end-to-end cold chain management solutions.

Expansion of Global Biopharmaceutical Supply Chains Driving Market Growth

The expansion of global biopharmaceutical supply chains is another important factor supporting the pharma & healthcare logistics market. Pharmaceutical and biotechnology companies increasingly manufacture products across multiple countries while sourcing raw materials, active pharmaceutical ingredients, packaging materials, and other inputs from suppliers located across different regions.

This has resulted in complex supply chains requiring coordinated transportation, warehousing, customs clearance, inventory management, and distribution services. The commercialization of biologics, biosimilars, monoclonal antibodies, cell and gene therapies, and specialty medicines is increasing the need for logistics networks capable of managing high-value and temperature-sensitive products.

Growing international pharmaceutical trade and improving healthcare access in emerging economies are supporting cross-border shipment volumes. Logistics providers are responding through integrated transportation networks, regional distribution centers, digital supply chain platforms, and shipment tracking services.

IoT-enabled tracking, GPS monitoring, predictive analytics, and automated inventory management are also helping improve operational efficiency and reduce supply chain risks. Continued expansion of pharmaceutical manufacturing and distribution networks is expected to increase demand for reliable, compliant, and scalable healthcare logistics services.

Expansion of Direct-to-Patient and Home Healthcare Logistics Creates Significant Opportunities

The increasing adoption of direct-to-patient delivery models and home healthcare services is creating new opportunities in the pharma & healthcare logistics market. Rising prevalence of chronic diseases, population aging, and growing preference for home-based treatment are increasing demand for reliable delivery of prescription medicines, specialty drugs, infusion therapies, and medical devices.

Growth in telemedicine, remote patient monitoring, and digital health platforms is further increasing the requirement for dependable last-mile healthcare logistics. Logistics providers are adopting advanced cold chain packaging, real-time shipment tracking, route optimization, and secure delivery systems to support patient-focused distribution models.

Pharmaceutical companies are increasingly collaborating with specialized logistics providers to improve patient access, support treatment compliance, and manage healthcare delivery costs.

The commercialization of personalized medicines, cell and gene therapies, and home-administered biologics is expected to further strengthen demand for specialized logistics services. Decentralized manufacturing and in situ production of cell therapies can also create opportunities for scalable cell-banking and supply chain solutions.

Providers capable of integrating specialized storage, transportation, monitoring, and patient delivery services can address the evolving requirements of personalized and home-based healthcare.

Transportation Segment Dominating the Global Pharma & Healthcare Logistics Market

The transportation segment dominated the global pharma & healthcare logistics market in 2025, accounting for approximately 43.1% of total market revenue. Transportation plays a central role in ensuring timely, secure, and compliant movement of pharmaceutical products across domestic and international supply chains.

Pharmaceutical manufacturers, biotechnology companies, hospitals, pharmacies, and distributors rely on road, air, sea, and rail transportation networks to move medicines, vaccines, biologics, medical equipment, and clinical trial supplies.

The increasing volume of temperature-sensitive products, including biologics, cell and gene therapies, and specialty pharmaceuticals, is driving greater adoption of validated cold chain transportation combined with real-time temperature monitoring and shipment tracking.

Growing international pharmaceutical trade, cross-border distribution, and outsourcing of logistics operations are further supporting demand for specialized transportation services. Good Distribution Practice requirements and other regulations are encouraging logistics providers to invest in refrigerated vehicles, insulated packaging, GPS-enabled fleet management, and digital monitoring technologies.

Expansion of healthcare infrastructure in emerging economies and rising pharmaceutical exports are also supporting transportation demand, reinforcing the segment's role within the global healthcare logistics ecosystem.

→Explore Strategies & Trends - Request Full Report Access – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86988

Pharma & Healthcare Logistics Market Regional Outlook

North America dominated the global pharma & healthcare logistics market in 2025, accounting for approximately 39.5% of total market revenue. The region benefits from an established pharmaceutical industry, developed healthcare infrastructure, and extensive cold chain logistics capabilities.

North America is home to numerous major pharmaceutical, biotechnology, and medical device companies requiring specialized transportation, warehousing, and distribution services. The commercialization of biologics, specialty pharmaceuticals, vaccines, and cell and gene therapies is increasing demand for temperature-controlled logistics solutions capable of maintaining product integrity.

The region also has established regulatory frameworks and traceability requirements, encouraging investment in advanced logistics infrastructure and digital monitoring systems.

Modern transportation infrastructure, advanced warehousing facilities, IoT-based tracking, automation, and real-time shipment visibility further support supply chain efficiency. Growing clinical trial activity, high healthcare expenditure, and increasing demand for direct-to-patient delivery services are also contributing to regional market development.

Strategic investments by logistics providers and pharmaceutical companies in cold chain capacity and integrated distribution networks are expected to support North America's leading position.

Logistics Type and Product Analysis

Based on logistics type, the market is segmented into cold chain logistics and non-cold chain logistics. Cold chain logistics is further categorized into controlled ambient, refrigerated, frozen, ultra-low-temperature, and cryogenic logistics.

Cold chain services are particularly important for biologics, vaccines, cell and gene therapies, specialty medicines, and other products whose quality can be affected by temperature fluctuations.

Based on product type, the market covers pharmaceutical products, biopharmaceuticals, vaccines, cell and gene therapies, clinical trial materials, medical devices, in vitro diagnostic products, blood and blood components, human tissue and organ transport, and others.

Pharmaceutical products include active pharmaceutical ingredients and finished pharmaceutical products, creating diverse logistics requirements across manufacturing, distribution, clinical research, and patient delivery.

Transportation Mode and End-user Analysis

By transportation mode, the pharma & healthcare logistics market is segmented into road, air, rail, and sea. Each transportation mode serves different requirements related to shipment distance, product sensitivity, delivery speed, cost, and geographical accessibility.

Road transportation plays an important role in domestic and last-mile distribution, while air transportation supports time-sensitive international shipments. Rail and sea transportation provide additional options for large-scale and long-distance movement of healthcare products.

Based on end-user, the market is categorized into pharmaceutical companies, biotechnology companies, medical device manufacturers, hospitals and clinics, diagnostic laboratories, CROs and CDMOs, retail and specialty pharmacies, government and public health agencies, and others.

Competitive Landscape

Key companies operating in the pharma & healthcare logistics industry are investing in strategic partnerships, infrastructure expansion, digital technologies, and cold chain capabilities. These initiatives are aimed at strengthening distribution networks, increasing supply chain visibility, and improving the secure handling of increasingly complex healthcare products.

Prominent players include DHL Group, Kuehne+Nagel International AG, UPS Healthcare, FedEx Corporation, DB Schenker, DSV A/S, GEODIS, CEVA Logistics, A.P. Møller - Mærsk A/S, Nippon Express Holdings, Inc., Lineage, Inc., Cencora, Inc., McKesson Corporation, Cardinal Health, Inc., and Yusen Logistics Co., Ltd.

Companies are focusing on temperature-controlled infrastructure, digital monitoring, automated warehousing, specialized transportation, direct-to-patient delivery, and integrated supply chain solutions.

These companies are profiled based on company overview, financial performance, business strategies, product and service portfolios, business segments, geographical presence, sales footprint, and recent developments.

Key Developments in the Pharma & Healthcare Logistics Market

In July 2026, Cencora announced plans to invest USD 1 Bn through 2030 to expand its pharmaceutical supply chain network. The investment includes a new distribution center in Ohio and improvements to facilities in California and Alabama, with emphasis on increasing cold chain capacity for biologics and specialty medicines.

In May 2026, Kuehne+Nagel expanded its healthcare logistics network by establishing a temperature-controlled airfreight cross-dock facility in Hyderabad, India. The facility is intended to strengthen cold chain capabilities and pharmaceutical air logistics for healthcare shipments within India and international markets.

In September 2025, Cardinal Health announced plans to construct a new pharmaceutical distribution center in Indianapolis. The automated facility is designed to support increasing specialty pharmaceutical volumes, improve supply chain efficiency, and strengthen distribution capacity for advanced therapies and temperature-sensitive medicines.

In April 2025, DHL Group announced an investment of €2 Bn in DHL Health Logistics through 2030 to expand its life sciences and healthcare logistics capabilities. The investment covers temperature-controlled infrastructure, cold chain capacity, pharmaceutical hubs, and digital monitoring solutions for biologics, clinical trials, and advanced therapies.

Future Outlook for the Pharma & Healthcare Logistics Market

The global pharma & healthcare logistics market is projected to expand from USD 102.0 Billion in 2025 to USD 216.8 Billion by 2036, representing a CAGR of 7.1% from 2026 to 2036.

The increasing commercialization of biologics, vaccines, specialty medicines, cell and gene therapies, and other temperature-sensitive healthcare products is expected to sustain demand for advanced cold chain infrastructure. At the same time, increasing pharmaceutical trade and increasingly complex global supply chains are creating demand for integrated transportation, warehousing, monitoring, and distribution solutions.

Direct-to-patient delivery and home healthcare represent important areas of future opportunity as healthcare delivery models become increasingly decentralized. The growth of telemedicine, remote patient monitoring, personalized medicine, and home-administered therapies is expected to increase the need for secure and reliable last-mile healthcare logistics.

Digitalization will remain another important component of market development. IoT-enabled tracking, GPS monitoring, predictive analytics, automation, RFID, cloud-based supply chain platforms, and real-time temperature monitoring are improving visibility and helping logistics providers manage complex pharmaceutical supply chains.

North America is expected to remain an important regional market due to its established pharmaceutical and healthcare ecosystem, while expanding pharmaceutical production, clinical research, and healthcare infrastructure across emerging economies will create additional opportunities. The combination of cold chain demand, global biopharmaceutical supply chain expansion, direct-to-patient delivery, and digital transformation is expected to support continued growth of the pharma & healthcare logistics market through 2036.

Buy Full Report Now: https://www.transparencymarketresearch.com/checkout.php?rep_id=86988<ype=S

→Explore Latest Research Reports by Transparency Market Research:

Pharmaceutical Water Market

Prosthetic Disc Nucleus Market

Mesotherapy Market

Medical Rehabilitation Services Market

Lip Augmentation Market

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Media Contact: 

Abhishek Budholiya

Transparency Market Research Inc.

State Tower, 90 State Street, Suite 700,

Albany NY - 12207, United States

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com 

Sales Inquiries: sales@transparencymarketresearch.com

Media Inquiries: media@transparencymarketresearch.com